This column has been updated to clarify the roles of Platform Computing and its development partners in the fourth item.
Aureus Pharma has released DDI Predict, a software application designed to automatically calculate the risk of drug-drug interactions associated with cytochrome P450s and provide a graphical report. The analysis of potential DDI risk is based on the US Food and Drug Administration’s latest risk classification, according to the company.
CLC Bio has released CLC RNA Workbench, a software platform for RNA secondary structure prediction based on free energy minimization algorithms.
A free trial of CLC RNA Workbench is available here.
DNAStar said this week that its ArrayStar microarray data-analysis software is now compatible with Affymetrix arrays under the company’s GeneChip-compatible applications program.
Platform Computing announced at the International Supercomputing Conference in Dresden, Germany, this week that it has collaborated with Intel to develop the Intel Cluster Ready Program.
Platform said that its Open Cluster Stack, the first commercial software system that creates "certified" Intel Cluster Ready systems, will be provided to the program. The Intel Cluster Ready program was designed to streamline the process of implementing Linux clusters.
Speaking to BioInform from the conference, Gary Tyreman, vice president and business manager of high-performance computing at Platform, said that the launch of the program, of which Platform is a part, is the culmination of about two years' worth of work with Intel and Dell.